Beruflich Dokumente
Kultur Dokumente
STASE MATA
Corneal Ulcer:
Diagnosis and Management
Prashant Garg MS In this article we focus on the diagnosis
Gullapalli N Rao MD and management of suppurative corneal
Sight Savers’ Corneal Training Centre ulcer.
L V Prasad Eye Institute
L V Prasad Marg Diagnosis
Banjara Hills Fig.1. Ring infiltrate in Acanthamoeba
A detailed history and thorough clinical keratitis
Hyderabad 500 034, India Photo: P Garg & G N Rao
examination using the slit-lamp biomicro-
Introduction scope are important steps in the diagnosis
of corneal ulcer. Although clinical signs Acanthamoeba keratitis, is rarely experi-
The Journal of Community Eye Health is published four times a Community Eye Health Vol 12 No. 30 1999
year. Free to Developing Country Applicants
1999/2000 Subscription Rates for Applicants Elsewhere
1 Year: UK£25 / US$40 2 Years: UK£45/ US$70
(4 Issues) (8 Issues)
To place your subscription, please send an international cheque/banker’s order made
payable to UNIVERSITY COLLEGE LONDON or credit card details with a note
of your name, full address and occupation (in block capitals please) to the address
below.
Journal of Community Eye Health, International Centre for Eye Health,
Institute of Ophthalmology, 11 – 43 Bath Street, LONDON, EC1V 9EL, UK
Dr Masresha Abuhay, Dean of Gonder
Medical College, Ethiopia received a copy
of Community Eye Health from the
Editor’s son, David McGavin
Photo: James Moult
FOCUS
Background
Eyelid eversion
It is important to note any previous eye conditions. If there is no sign of penetration, the upper and lower eyelids
Concurrent contact lens use is an indication for referral of both eyes should always be single everted (Figure 2A) to
because of the risk of severe infection with unusual organisms. examine for foreign bodies on the tarsal plate (Figure 2B),
Do not commence antibiotics as microbiological specimens and the upper lids double everted (Figures 2C, D) to look for
may need to be taken. Take care to ensure that amblyopia or foreign bodies in the upper fornix. These can be easily
pre-existing poor vision in an eye is not mistaken for a missed, causing
reduction in visual acuity associated with a foreign body.
Examination
The equipment required for the office-based examination and
removal of a corneal foreign body is outlined in Box 1.
Visual acuity
This is the most important but often overlooked parameter to
document in the patient’s medical notes. If there are no available
hard copies of a Snellen chart, it is sufficient to use those
Positioning
Lay the patient in a comfortable supine position, with the
involved eye closest to the attending clinician. Wear
loupes if they are available and illuminate the eye with a
medical
light or, alternatively, use the light and magnification from the
ophthalmoscope held in the non-dominant hand. Unfortunately,
the ophthalmoscope does not facilitate stereopsis. Ask the
patient to focus on a particular point on the ceiling so that the
foreign body sits as centrally between the lids as possible.
Avoiding the lids and lashes is more sterile, and reduces the
chance of eliciting a blink reflex. If necessary, the eyelids can
be kept open using an eyelid speculum, the examiner’s
fingertips, a cotton tip or an assistant.
© The Royal Australian College of General Practitioners REPRINTED FROM AFP VOL.46, NO.3, MARCH 2017 91
2017
should come from the finer joints of the fingers, with the hand in pain, photophobia, redness, epithelial defect size or
resting on a firm point of contact. opacity may indicate the onset of keratitis and requires a
The aim of the procedure is the safe and complete removal of referral.
the foreign body and any surrounding rust ring (Figure 3A–D). Topical antibiotics in the form of ointment or drops, which
It is best to accomplish this in one to two sittings in total, so if are less blurring, are continued four times a day for five to
there is any doubt this has not been achieved then referral for seven days. This visit is also an opportune time for patient
slit lamp education on the importance of wearing eye protection while
examination and complete removal is advised. The site of a undertaking activities that pose risks. A certificate of leave
residual rust ring, even at the peripheral cornea, is at risk of from work or study for one to two days is not unreasonable.
infection and recurrent erosion. The flat part of the 15 blade tip
can be useful to remove the rust ring (Figure 3D). Dental burrs Paediatrics
should be avoided because of the risk of deeper damage to the Patients younger than 10 years of age are much less likely to
corneal stroma and infection from the usual non-sterile status of tolerate examination and foreign body removal. Irrigation and
the instrument. removal with a cotton tip can be attempted after instillation of
topical anaesthetic drops, provided the patient’s head can be
Irrigation stabilised with safety. If there is any concern, the patient needs
Irrigation of the ocular surface and upper and lower fornices to be referred to a paediatric facility where examination and
can be performed after the procedure to wash out any residual treatment under general anaesthesia are possible.
loose foreign body material. A 10 mL ampoule of sterile saline Referral and prognosis
is usually sufficient.
Most corneal foreign bodies result in minimal superficial
Post-procedure scarring of no visual significance. However, removal of a
corneal foreign body without the aid of a slit-lamp can be a
Antibiotic ointment such as chloramphenicol 0.5% should be challenging procedure, and if the GP does not feel safe to
instilled and a double eye pad applied, with the inner one doubled proceed, referral to an ophthalmologist is warranted. This
over in a manner that the eyelid cannot be opened. The patient pertains particularly to central and paracentral corneal foreign
needs instruction not to drive or operate machinery while wearing bodies that are deeper than expected. Even when removed
the eye pad. This must be documented clearly in the patient’s with minimal iatrogenic trauma, this location caries a higher
medical notes. Generally, eye pads are kept on for a period of risk of a visually significant corneal scar. Pertinent indications
24 hours to expedite healing of the epithelial defect and for for referral are summarised in Box 2.
pain relief. An alternative approach is to omit the eye pad but
use the antibiotic ointment or drops four times a day. This Key points
depends on the doctor’s and patient’s preference. The literature • Initial assessment and management of corneal foreign bodies is
strongly suggests that there is no difference in time to healing within the scope of a GP.
or complication rate with or without patching.11,12 Over-the- • A moistened cotton bud, 25G hypodermic needle or 15 blade is a
counter oral analgesia can be used for pain relief. Do not suitable approach for superficial foreign bodies and rust rings in
discharge the patient with topical anaesthetic drops; these result the office provided there is good light, adequate magnification
in an increased complication rate from corneal anaesthesia.13 and a cooperative patient.
Laboratory research also suggests time-dependant and dose- • Referral to an ophthalmologist is indicated if there are any
dependant toxicity.14 concerns.
The patient can be examined the following day to measure Authors
visual acuity again and repeat fluorescein staining. Any
increase Alison Fraenkel BBiomedSc, MBBS, Preclinical Fellow, City Eye Centre,
Brisbane, Qld
Lawrence R Lee MBBS, FRANZCO, FRACS, Associate Professor, City Eye
Centre, University of Queensland; Royal Brisbane & Womens Hospital, Brisbane,
Qld. eye@cityeye.com.au
Box 2. Indications for referral to an ophthalmologist Graham A Lee MD, MBBS, FRANZCO, Associate Professor, City Eye Centre,
University of Queensland; Mater Hospital, Brisbane, Qld
• Penetrating eye injury or intraocular foreign body Competing interests: None.
• Incomplete removal or practitioner uncertainty Provenance and peer review: Commissioned, externally reviewed.
• Persisting foreign body symptoms
References
• Persisting rust ring 1. The Royal Australian College of General Practitioners. Curriculum for Australian
• Persisting vision loss General Practice 2016 – EY16: Eye medicine contextual unit. East Melbourne,
Vic: RACGP, 2016.
• Keratitis
• Endophthalmitis
• Persisting epithelial defect
• Recurrent erosion
• Paediatric or uncooperative patients that may require
examination under anaesthesia
2. The Royal Australian College of General Practitioners. Curriculum for Australian
General Practice 2016 – CS16: Core skills unit. East Melbourne, Vic: RACGP, 2016. 11. Lim CHL, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database
3. Gerstenblith AT, Rabinowitz MP. The wills eye manual: Office and emergency Syst Rev 2016(7):CD004764.
room diagnosis and treatment of eye disease. 6th edn. Philadelphia: Lippincott 12. Menghini M, Knecht PB, Kaufmann C, et al. Treatment of traumatic corneal
Williams & Wilkins, 2012. abrasions: A three-arm, prospective, randomized study. Ophthalmic Res
4. Sehu W. Emergency eye manual. 2nd edn. North Sydney: NSW Department of 2013;50(1):13–18.
Health, 2009. 13. Erdem E, Undar IH, Esen E, Yar K, Yagmur M, Ersoz R. Topical anesthetic eye
5. Pidduck HR, Dillon MJ. Management of acute eye injuries in primary care. drops abuse: Are we aware of the danger? Cutan Ocul Toxicol 2013;32(3):189–93.
InnovAiT 2014;7(9):526–32. 14. Fan WY, Wang DP, Wen Q, Fan TJ. The cytotoxic effect of oxybuprocaine on
6. Sridhar MS, Ramakrishnan M. Ocular lesions caused by caterpillar hairs. Eye human corneal epithelial cells by inducing cell cycle arrest and mitochondria-
2004;18(5):540–43. dependent apoptosis. Hum Exp Toxicol 2016; doi: 10.1177/0960327116665676.
7. University of Otago. Clinical optics: Ophthalmoscope. Otago: University of Otago,
2005. Available at https://f0031a47d0539cbdd2b0-98b3320022afa2702e2
b713806f9b5f9.ssl.cf4.rackcdn.com/ob3v1/Otago-Ophthalmology/Clinical-Optics/
ClinicalOptics.html [Accessed 11 January 2016].
8. Jayamanne DG. Do patients presenting to accident and emergency departments with
the sensation of a foreign body in the eye (gritty eye) have significant ocular
disease? J Accid Emerg Med 1995;12(4):286–87.
9. Ahmed F, House RJ, Feldman BH. Corneal abrasions and corneal foreign bodies. Prim
Care 2015;42(3):363–75.
10. MIMS Online [Internet]. St Leonards, NSW: MIMS Australia
Pty Ltd, 2017. Available at https://www.mimsonline.com.
au/Search/QuickSearch.aspx?ModuleName=Product%20
Info&searchKeyword=Atropine+sulfate&FieldName=GenericName [Accessed 9
February 2017].
RESEARCH ARTICLE
Abstract
OPEN ACCESS Competing interests: The authors have declared that no competing interests exist.
Methods
We investigated objective
parameters of the ocular surface
such as conjunctival hyperemia,
tear film stability and volume,
meibomian gland dysfunction, dry
eye disease, corneal topog-
raphy comparing healthy
individuals and correlating with
the pterygium clinical
presentation.
Results
A total of 83 patients were
included. Corneal astigmatism
induction was 2.65 ± 2.52 D (0.4–
11.8). The impact of pterygium on
the ocular surface parameters
compared to matched con- trols
was seen in: conjunctival
hyperemia (control
1.55±0.39/pterygium 2.14±0.69; p
= 0.0001), tear meniscus height
(control 0.24±0.05 mm/pterygium
0.36±0.14mm; p 0.0002),
meiboscore lower eyelid (control
0.29±0.64/pterygium 1.38±0.95; p
0.0001) and meiboscore upper
eyelid (control
0.53±0.62/pterygium 0.98±0.75; p
= 0.0083). We found a high
number of pterygium patients
(88%) presented meibomian
gland alterations. Interestingly,
meibo- mian gland loss was
coincident to the localization of
the pterygium in 54% of the upper
and 77% lower lids.
Conclusion
Introduction
Pterygium is a non-neoplastic elastotic degeneration originated in the bulbar conjunctiva that
extends to the corneal surface. It can cause symptoms of discomfort, corneal irregularities, aes-
thetics issues thus compromising visual acuity and patients‘quality of life. [1–3] The prevalence of
pterygium varies worldwide. Global prevalence was estimated in 10.2% to 12%, reaching higher
numbers in tropical regions. Several risk factors have been associated with pterygia, such as
geographical latitude, residence in rural areas, old age, race, sex, sun exposure, chronic irritation
and inflammation. [4,5]
Some studies have pointed to tear film and ocular surface varying changes related to pteryg-
ium, but consistent correlations remain unknown. [6–9] Although numerous theories have been
listed in the pathogenesis of the pterygium (e.g. exposure to ultraviolet radiation, viral infection,
oxidative stress, genetic problems, inflammatory mediators, extracellular matrix modulators) the
mechanism responsible development remains controversial. [10] And a better understanding of the
pathophysiological mechanisms associated with pterygium, the morpho- logical alterations on the
ocular surface and functional impact may contribute to specific approaches and more effective
therapeutic proposals for this common ocular condition.
This study aimed to evaluate how ocular surface parameters correlate with pterygium clini- cal
presentation and its impact on ocular surface structures and homeostasis.
2 / 10
translated into a color-coded map. When the corneal image is aligned the following mes- sage
appears: [Please blink 2 times] and measurement are taken automatically. "Break (first)" gives
the moment when the first break is detected on any surface segment. Break (Mean) gives the
mean breaking time for all surface segments where the rupture occurred.
2. Tear meniscus height measured in millimeters in images taken by Keratograph
5M equipment.
3. Meibomian Gland Function: non-contact infrared meibography was performed in the
lower and upper lid using Keratograph 5M. Gland dropout was assessed using meiboscan
infrared device according to the instructions. Meiboscore was used for assessment of the
meibography in the evaluation of the infrared captured images of the meibomian glands.
The classification scale, adapted from Arita et al., used the following degrees for each
eyelid: 0 (no loss of meibomian glands); 1 (loss of the meibomian gland involving less
than one- third of the total meibomian gland area); 2 (loss between one third and two
thirds of the total area of the meibomian gland); and 3 (loss more than two-thirds of the
total meibomian gland area). [11]
4. Pterygium evaluation: pterygium patients were classified according their graduation:
grade 1 to 4 according to fibrovascular tissue extension towards the cornea (grade 1 when
the lesion reaches the limbus, grade 2 when it covers the cornea at about 2 mm, grade 3
when it reaches the pupil margin and grade 4 when it exceeds the pupil). Indeed,
biomicroscopic aspect was noted as involutive atrophic or fleshy (involutive allows the
visualization of structures immediately below and fleshy when fibrovascular tissue
prevents proper visuali- zation of underneath structures). [12] Hence, corneal topography
images were taken for keratometries and astigmatism measurements.
Exploratory data analysis was performed through summary measures (mean, standard
deviation, minimum, median, maximum, frequency and percentage). Comparison between groups
was performed using the Wilcoxon test. The correlation between numerical variables was assessed
using the Spearman coefficient. The level of significance was 5%. The analyses were performed
using the computer program The SAS System for Windows (Statistical Analy- sis System),
version 9.4. (SAS Institute Inc, Cary, NC, USA).
Results
A total of 83 patients were included in this study (52 pterygium patients and 31 healthy volun-
teers). Mean age of 53.69 ± 11.29 (26–75) years old in pterygium groups and 57.32 ± 7.30 (39–
72) in healthy participants (p = 0.6084).
Pterygia classification regarding tissue progression from limbus to the visual axis was: 1.9%
as grade 1; 59.5% grade 2; 32.7% grade 3; and 5.8% as grade 4 (tissue over visual axis). In addi-
tion, 15.4% were atrophic and 84.6% had a fleshy/active clinical appearance. Corneal astigma-
tism induction was 2.65 ± 2.52 D (0.4–11.8). Table 1 shows ocular surface parameters in
pterygium patients and controls and Table 2 shows data distribution according to the pteryg- ium
grades and appearance (Table 3).
Compared to control participants, pterygium patients presented significant alterations regarding
hyperemia (control 1.55±0.39–95% CI 0.02–0.34; pterygium 2.14±0.69–95% CI 1.95–
2.36; p 0.0001), tear meniscus height (control 0.24±0.05 mm- 95% CI 0.22–0.26; pterygium 0.36
±0.14mm—95% CI 0.32–0.40; p 0.0002) and meiboscore lower eyelid (control 0.29±0.64–95%
CI 0.05–0.52; pterygium 1.38±0.95–95% CI 0.77–1.19; p 0.0001) and meiboscore upper eyelid
(control 0.53±0.62–95% IC 0.29–0.76; pterygium 0.98±0.75–95% IC 0.77–1.19; p 0.0083).
Table 1. Comparisons of ocular Surface parameters in pterygium and healthy participants.
Control Pterygiu
m
Mean ± SD 95% CI Mean ± SD 95% CI P value
Age 57.32±7.30 5.76–14.43 53.69±11.2 50.55– 0.6084
(years) 9 56.84
Visual Acuity 0.85±0.21 0.77–0.94 0.63±0.31 0.54–0.71 0.0001�
Tear meniscus height 0.24±0.05 0.22–0.26 0.36±0.14 0.32–0.40 0.0001�
NITBUT first Breakup 10.6±6.51 8.22–13.01 10.64±5.29 9.16–12.11 0.8728
NITBUT average Breakup 14.28±6.06 11.88–16.68 13.55±5.55 12.01– 0.6605
15.10
Conjunctival hyperemia 1.55±0.39 0.02–0.34 2.14±0.69 1.95–2.36 0.0001�
Meiboscore lower 0.29±0.64 0.05–0.52 1.38±0.95 0.77–1.19 0.0001�
Meiboscore upper 0.53±0.62 0.29–0.76 0.98±0.75 0.77–1.19 0.0083�
https://doi.org/10.1371/journal.pone.0213956.t001
We found that 88% of patients presented abnormalities on meibomian glands. Interest- ingly, in
54% of the upper eyelids and 77% of the lower eyelids, the meibomian gland loss appeared nasally
in the same localization of the pterygium. Fig 1 shows the distribution of the meibomian gland
involvement in the upper and lower eyelid and Fig 2 exemplifies the meibo- graphy alterations in
pterygium patients. Indeed, correlation analysis according to both pte- rygium classifications were
performed and corroborated to these findings. Regarding to the extension over the limbus in grades
1–4 meiboscore, significant correlations to the localization of the pterygium in both eyelid were
demonstrated and when evaluating by clinical appearance atrophic pterygium meiboscore superior
correlated with inferior compromise and in fleshy ones, both meiboscores correlated with the
pterygium localization, as shown in Tables 4 and 5.
Regarding the subjective symptoms, the patients’ complaints were evaluated as parameters
such as tearing, ocular discomfort, aesthetics and blurred vision. Such symptoms are closely
related to the tear film and ocular surface abnormalities described.
Discussion
The present study shows that pterygium has a great impact on the parameters and structures of the
ocular surface. It can induce corneal astigmatism, conjunctival hyperemia, tear film abnormalities
and significant structural alterations in the meibomian glands.
Table 2. Data distribution according to pterygium extension over the limbus (grades 1–4).
Grades 1– Grades 3–
2 4
Mean ± SD 95% CI Mean ± SD 95% CI P value
Age (years) 51.5 ± 11.3 47.3–55.6 57.1 ± 10.9 52–62.2 0.09
K1 43.2 ± 2 42.5–44 42.8 ± 3.8 40.7–45 0.92
K2 44.9 ± 1.9 44.1–45.6 47.5 ± 3.2 45.7–49.3 0.001�
Corneal astigmatism 1.6 ± 1.1 1.1–2 4.6 ± 3.3 2.7–6.4 0.006�
(pterygium)
NITBUT 9.8 ± 4.8 8.1–11.6 9.9 ± 5.1 7.6–12.3 0.95
Conjunctival hyperemia 2.7 ± 0.6 2.4–2.9 2.7 ± 0.6 2.4–3 0.96
Tear meniscus height 0.3 ± 0.1 0.3–0.4 0.3 ± 0.1 0.2–0.4 0.27
Red eye (0–10) 7.7 ± 3 6.3–9.1 8 ± 2.1 6.7–9.4 0.96
Irritation (0–10) 7.1 ± 1.7 6.3–7.9 6.5 ± 3.4 4.3–8.6 0.92
Tearing (0–10) 5.8 ± 3.6 4.1–7.4 6 ± 3.9 3.4–8.5 0.76
Blurred vision (0–10) 6.7 ± 3.5 5.1–8.3 7.2 ± 2.9 5.4–9 0.95
Aesthetics (0–10) 7.9 ± 3 6.5–9.3 7.5 ± 3.2 5.4–9.5 0.66
https://doi.org/10.1371/journal.pone.0213956.t002
Table 3. Data distribution according to the pterygium clinical presentation (atrophic and fleshy).
Atrophic Fleshy
Mean ± SD 95% CI Mean ± SD 95% CI P value
Age (years) 58.5 ± 13.3 47.3–69.6 52.8 ± 10.8 49.5–56.1 0.26
K1 42.7 ± 3.3 40–45.5 43.2 ± 2.5 42.3–44 0.40
K2 46.2 ± 5.2 41.8–50.6 45.7 ± 1.8 45–46.2 0.40
Corneal astigmatism 3.5 ± 2.7 1.1–5.8 2.4 ± 2.4 1.6–3.2 0.18
(pterygium)
NITBUT 9.5 ± 7.1 3.5–15 10 ± 4.5 8.7–11.5 0.36
Conjunctival hyperemia 2.3 ± 0.1 2.5–2.9 2.7 ± 0.7 1.8–2.9 0.005�
Tear meniscus height 0.4 ± 0.2 0.2–0.6 0.3 ± 0.1 0.31–0.39 0.25
Red eye (0–10) 9±1 7.7–10 7.7 ± 2.8 6.6–8.8 0.82
Irritation (0–10) 7±2 4.5–9.4 6.8 ± 2.5 5.9–7.8 0.51
Tearing (0–10) 6.4 ± 2.6 3–9.6 5.8 ± 3.8 4.4–7.3 0.92
Blurred vision (0–10) 8.8 ± 1 7.4–10 6.7 ± 3.4 5.4–7 0.25
Aesthetics (0–10) 7 ± 2.9 3.3–10.6 8±3 6.8–9 0.34
https://doi.org/10.1371/journal.pone.0213956.t003
Ocular hyperemia can be considered as a clinical sign of inflammation that may suggest severity
and progression of a specific disease. [13] High rates of hyperemia were observed in the eyes with
pterygium, which may be explained by the number of fleshy pterygia present in this study and by
the richer vascularization of the pterygium itself, even in the atrophic ones. The advantage of using
the image analysis method is that one can eliminate individual variabil- ity and the bias of
subjective classification. [14]
Although pterygium symptoms resemble dry eye and others ocular surface diseases symp- toms,
such as dryness and irritation, no decrease on non-invasive tear break-up time (NIT- BUT) was
observed in this cohort. A study carried out in 2014 had already shown that the size of the
pterygium does not correlate with the tear break-up time and the results of the Schir- mer‘s test.
[15] Another study comparing Schirmer’s test results and tear break-up time before and after
pterygium surgery showed that, even with the removal of the pterygium, there were no changes in
those tests results one month after surgery. [16] On the other hand, Ozsutcu
et al. found lower values of tear film test and Schirmer I test in eyes with pterygium when com-
pared to healthy eyes, which can be explained by the significantly higher tear osmolarity levels
Fig 1. Meiboscore classification in control individuals (blue: lower eyelid; green: upper eyelid) and pterygium patients
(yellow: lower eyelid; red: upper eyelid).
https://doi.org/10.1371/journal.pone.0213956.g001
Fig 2. Examples of meibography alterations in pterygium patients where gland dropout (yellow arrow) occurred along
with the topography of the fibrovascular tissue (red arrow) upper eyelid (grade 2; grade 2; grade 1) and lower eyelid
(grade 1; grade 2; grade 2) respectively.
https://doi.org/10.1371/journal.pone.0213956.g002
found in the study.[6] In our study pterygium patients had statistically higher tear meniscus height
and no differences in NITBUT, which may be pointed as a picture of the ocular surface
compensatory mechanisms. Higher measurements of tear meniscus may be related to chronic
ocular inflammation and friction and abnormal distribution of tear film leading to surface dis-
turbances in tear flow dynamics and reflex tearing, as described in previous studies.[16] Although,
normal tear function and no alteration on tear meniscus height has been already described in the
pterygium patients [14,17]
Pterygium can induce corneal aberrations that compromise patients’ visual acuity. Studies
indicate the length of the pterygium and vascularization as predictive factors for increased induction
of astigmatism.[17–19] On the other hand, pterygium excision leads to a decrease in acquired
astigmatism to acceptable levels, as shown by studies that evaluated the impact of sur- gery on
corneal astigmatism reduction.[20] Regarding the surgical procedure, there was no significant effect
on the degree of astigmatism were found comparing different surgical tech- niques.[21]
Table 4. Correlations between meibomian gland dysfunction and ocular surface parameters according to pterygium grades (1–4).
Grade 1–2 Grade 3–
4
Meiboscore Meiboscore Meiboscore Meiboscore
superior inferior superior inferior
K1 0.037 0.287 0.444 0.426
K2 0.212 0.093 0.580� 0.262
CA 0.309 -0.226 -0.198 -0.402
NITBUT 0.151 0.050 0.085 -0.425
TMH 0.213 0.226 0.090 0.213
CH -0.042 0.190 0.154 0.293
Meiboscore superior 0.277 0.483�
MGD/PTCOL 0.578 � 0.069 0.580 � 0.424
superior
Meiboscore inferior 0.277 0.483�
MGD/PTCOL inferior 0.147 0.557 �
0.521� 0.768�
Correlations coefficient value by Spearman analysis of Meibomian Gland Dysfunction and Pterygium extension over the limbus (grades 1–4).
�
P < 0.05. MG: Meibomian Gland; K: keratometry; CA: corneal Astigmatism; NITBUT: Non-Invasive Tear Breakup Time; TMH: Tear Meniscus Height; CH:
Conjunctival Hyperemia; MGD/PTCOL: MG drop dropout area/pterygium colocalization
https://doi.org/10.1371/journal.pone.0213956.t004
Table 5. Correlations between meibomian gland dysfunction and ocular surface parameters according to pterygium clinical appearance (atrophic and fleshy).
Atrophic Fleshy
Meiboscore Meiboscore Meiboscore Meiboscore
superior inferior superior inferior
K1 0.326 0.377 0.149 0.403
K2 -0.078 0.025 0.184 -0.011
CA -0.223 -0.107 0.181 -0.415�
NITBUT 0.299 -0.264 <0.000 -0.204
1
TMH 0.534 0.088 0.127 0.269
CH 0.143 0.529 -0.022 0.186
Meiboscore superior 0.800 0.277
MGD/PTCOL 0.276 0.266 0.590� 0.202
superior
Meiboscore inferior 0.800� 0.277
MGD/PTCOL inferior 0.690 0.800 0.234 0.616�
Correlations coefficient value by Spearman analysis of Meibomian Gland Dysfunction and Pterygium clinical appearance (atrophic/fleshy).
�
P < 0.05. MG: Meibomian Gland; K: keratometry; CA: corneal Astigmatism; NITBUT: Non-Invasive Tear Breakup Time; TMH: Tear Meniscus Height; CH:
Conjunctival Hyperemia; MGD/PTCOL: MG drop dropout area/pterygium colocalization
https://doi.org/10.1371/journal.pone.0213956.t005
Meibomian gland dysfunction (MGD) is a chronic and diffuse disorder occurs in meibo- mian
glands. The etiology of MGD includes primary causes which are not fully understood, and
secondary causes including ocular disorders such as blepharitis, conjunctivitis, etc., and systemic
disease such as lupus erythematosus, Sjogren syndrome. [22] MGD was found in a significant
number of pterygium patients. Interestingly, areas of meibomian gland loss coinci- dently
appeared in the nasal topographic localization of the pterygium, both in the upper and lower
eyelids. Wu et al described recently, a similar association of pterygium and MGD. This study
reported NIBUT, meibomian gland dropout and meibum score alterations in pterygium patients.[9]
However, besides these findings, by evaluating each patient meibography picture, an association
of the dropout area related to the topography of the pterygium was observed in a considered
number of cases, to our knowledge, no association with pterygium localization was described
before. [23]
The ocular surface homeostasis is crucial to guarantee comfort, quality of vision and proper
maintenance of all structures that compose this functional unit. Such peculiar relationship can be
profoundly changed by the loss of regularity promoted by the pterygium growth, as well as
changes meibomian gland and tear film changes described herein. However, a deep under-
standing of the underlying pathophysiological mechanisms related to those MGD and tear film
alterations still requires further investigation. We can hypothesized that those changes might be
related to local inflammatory conditions and the release of inflammatory cytokines that can spread
to the anterior and posterior margin of the eyelid, resulting in meibomian gland alterations, as seen
in other ocular surface disorders.[23] It was suggest direct inflamma- tory damage to eyelid due to
elevated inflammatory status and the release of inflammatory cytokines, including tumor necrosis
factor-α, interleukin-4, and interleukin-5, may spread to the anterior and posterior lid margin, thus
resulting in meibomian gland changes.[24] Indeed, chronic repeated inflammation might also
cause meibum stagnation followed by the keratini- zation of orifices in the meibomian glands.
[23] Another mechanism can be attributed to mechanic trauma, due to an effect of the direct
friction caused by the pterygium in the tarsal conjunctiva may play a contributory role. Similar
trauma condition have been studied in con- tact lens users, associated with adverse changes in
meibomian gland morphology and in the
condition of the lid margin and meibum, suggesting that contact lenses negatively affect mei-
bomian glands.[25]
However, this finding demands further exploration. Of note, meibomian gland proper pro-
duction and delivery is crucial to tear film stability and evaporative dry eye is considered the most
common subtype of disease affection a great number of individuals worldwide. Thus, dis- ruption of
meibomian gland function negatively impacts both the quality and quantity of mei- bum and in turn
affects ocular surface health. Increased tear evaporation, tear film instability and consequent
hyperosmolarity, inflammation and ocular surface damage lead to ocular dis- comfort and visual
disruption. The findings related to pterygium and meibomian gland described in this study, may
indicate a need of closer attention regarding to quantification of related symptoms, search of clinical
signs and overall preventive measurements to guarantee meibomian gland functional support, such
as eyelid hygiene, mechanical expression and other procedures.
Some limitations of this study must be pointed out. Our sample consisted of patients that
consecutively presented for consultation. Although with distinct grades according to the pro-
posed classification system, the included participants had primary, nasal pterygia. Recurrent and
temporally located pterygia may carry different features, not evaluated in this study. The use of
noninvasive technology for ocular surface study has proved to be of great value, but a broad
investigation of tear and tissue inflammatory mediators may enhance the understanding of
pterygium mechanisms and the ocular surface changes described herein.
This study demonstrated a detailed evaluation of the clinical parameters of the ocular sur- face in
the pterygium population and quantified the symptoms. Therefore, our results not only allowed for a
contribution to the understanding of the disease but also created new perspec- tives for future
studies.
Conclusion
The present study shows that pterygium impacts on ocular surface parameters, especially by
inducing direct alterations in the pattern of meibomian glands and tear film.
Supporting information
S1 Data. wanzeler.dataset.
(XLSX)
Author Contributions
Conceptualization: Ana Claudia Viana Wanzeler, Italo Antunes Franc¸a Barbosa, Bruna Duarte,
Monica Alves.
Data curation: Ana Claudia Viana Wanzeler, Italo Antunes Franc¸a Barbosa, Bruna Duarte,
Eduardo Buzolin Barbosa.
Formal analysis: Ana Claudia Viana Wanzeler, Italo Antunes Franc¸a Barbosa, Eduardo Buzo- lin
Barbosa, Daniel Almeida Borges.
Funding acquisition: Monica Alves.
Investigation: Ana Claudia Viana Wanzeler, Italo Antunes Franc¸a Barbosa, Eduardo Buzolin
Barbosa.
Methodology: Ana Claudia Viana Wanzeler, Italo Antunes Franc¸a Barbosa.
Project administration: Monica Alves.
Resources: Italo Antunes Franc¸a Barbosa, Bruna Duarte.
Supervision: Monica Alves.
Validation: Daniel Almeida Borges.
Visualization: Daniel Almeida
Borges.
Writing – original draft: Ana Claudia Viana Wanzeler.
Writing – review & editing: Italo Antunes Franc¸a Barbosa, Bruna Duarte, Eduardo
Buzolin Barbosa, Daniel Almeida Borges, Monica Alves.
References
1. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic epidemiology. 1999 Sep;
6(3):219–28. PMID: 10487976
2. Chui J, Girolamo N Di, Wakefield D, Coroneo MT. The Pathogenesis of Pterygium: Current Concepts and
Their Therapeutic Implications. The Ocular Surface [Internet]. 2008 Jan 1 [cited 2018 Mar 18]; 6 (1):24–
43. Available from: https://www.sciencedirect.com/science/article/pii/S1542012412701039 PMID:
18264653
3. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: A stem cell
disorder with premalignant features. American Journal of Pathology [Internet]. 2011 Feb; 178(2):817–
27. Available from: https://doi.org/10.1016/j.ajpath.2010.10.037 PMID: 21281814
4. Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a sys-
tematic review and meta-analysis. BMJ Open [Internet]. 2013/11/19. 2013; 3(11):e003787. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/24253031 https://doi.org/10.1136/bmjopen-2013-003787 PMID:
24253031
5. Rezvan F, Khabazkhoob M, Hooshmand E, Yekta A, Saatchi M, Hashemi H. Prevalence and risk fac- tors
of pterygium: a systematic review and meta-analysis. Survey of ophthalmology. 2018 Sep; 63 (5):719–35.
https://doi.org/10.1016/j.survophthal.2018.03.001 PMID: 29551597
6. Ozsutcu M, Arslan B, Erdur SK, Gulkilik G, Kocabora SM, Muftuoglu O. Tear osmolarity and tear film
parameters in patients with unilateral pterygium. Cornea. 2014 Nov; 33(11):1174–8. https://doi.org/10.
1097/ICO.0000000000000221 PMID: 25255132
7. Ergin A, Bozdoğan O¨ . Study on Tear Function Abnormality in Pterygium. Ophthalmologica [Internet].
2001; 215(3):204–8. Available from: https://www.karger.com/DOI/10.1159/000050859 PMID: 11340392
8. Chan CML, Liu YP, Tan DTH. Ocular surface changes in pterygium. Cornea. 2002 Jan; 21(1):38–42.
PMID: 11805505
9. Wu H, Lin Z, Yang F, Fang X, Dong N, Luo S, et al. Meibomian Gland Dysfunction Correlates to the
Tear Film Instability and Ocular Discomfort in Patients with Pterygium. Scientific Reports [Internet].
2017 Mar 24; 7:45115. Available from: https://doi.org/10.1038/srep45115 PMID: 28338041
10. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. The British journal of
ophthalmology. 2010 Jul; 94(7):815–20. https://doi.org/10.1136/bjo.2008.151852 PMID: 19515643
11. Arita R, Suehiro J, Haraguchi T, Shirakawa R, Tokoro H, Amano S. Objective image analysis of the mei-
bomian gland area. The British Journal of Ophthalmology [Internet]. 2014 Jun 27; 98(6):746–55. Avail- able
from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033206/ https://doi.org/10.1136/ bjophthalmol-2012-
303014 PMID: 23813417
12. Schellini SA, dos Reis Veloso CE, Lopes W, Padovani CR, Padovani CRP. Characteristics of patients with
pterygium in the Botucatu region. Arquivos brasileiros de oftalmologia. 2005; 68(3):291–4. PMID:
16059556
13. Murphy PJ, Lau JSC, Sim MML, Woods RL. How red is a white eye? Clinical grading of normal conjunc-
tival hyperaemia. Eye (London, England). 2007 May; 21(5):633–8.
14. Hilmi MR, Che Azemin MZ, Mohd Kamal K, Mohd Tamrin MI, Abdul Gaffur N, Tengku Sembok TM. Pre-
diction of Changes in Visual Acuity and Contrast Sensitivity Function by Tissue Redness after Pteryg- ium
Surgery. Current eye research. 2017 Jun; 42(6):852–6. https://doi.org/10.1080/02713683.2016. 1250277
PMID: 28118054
15. Kampitak K, Leelawongtawun W. Precorneal tear film in pterygium eye. Journal of the Medical Associa- tion
of Thailand = Chotmaihet thangphaet. 2014 May; 97(5):536–9. PMID: 25065094
16. Kampitak K, Tansiricharernkul W, Leelawongtawun W. A comparison of precorneal tear film pre and post
pterygium surgery. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2015 Mar; 98
Suppl 2:S53–5.
17. Han SB, Jeon HS, Kim M, Lee S-J, Yang HK, Hwang J- M, et al. Quantification of Astigmatism Induced by
Pterygium Using Automated Image Analysis. Cornea. 2016 Mar; 35(3):370–6. https://doi.org/10.
1097/ICO.0000000000000728 PMID: 26684048
18. Avisar R, Loya N, Yassur Y, Weinberger D. Pterygium-induced corneal astigmatism. The Israel Medical
Association journal: IMAJ. 2000 Jan; 2(1):14–5. PMID: 10892364
19. Oner FH, Kaderli B, Durak I, Cingil G. Analysis of the Pterygium Size Inducing Marked Refractive Astig-
matism. European Journal of Ophthalmology [Internet]. 2000 Jul 1; 10(3):212–4. Available from: https://
doi.org/10.1177/112067210001000304 PMID: 11071028
20. Khan FA, Khan Niazi SP, Khan DA. The impact of pterygium excision on corneal astigmatism. Journal of
the College of Physicians and Surgeons—Pakistan: JCPSP. 2014 Jun; 24(6):404–7. doi: 06.2014/
JCPSP.404407 PMID: 24953913
21. Altan-Yaycioglu R, Kucukerdonmez C, Karalezli A, Corak F, Akova YA. Astigmatic changes following
pterygium removal: comparison of 5 different methods. Indian journal of ophthalmology. 2013 Mar; 61
(3):104–8. https://doi.org/10.4103/0301-4738.109379 PMID: 23514644
22. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international
workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.
Investigative ophthalmology & visual science. 2011 Mar; 52(4):1930–7.
23. Ye F, Zhou F, Xia Y, Zhu X, Wu Y, Huang Z. Evaluation of meibomian gland and tear film changes in
patients with pterygium. Indian journal of ophthalmology. 2017 Mar; 65(3):233–7. https://doi.org/10.
4103/ijo.IJO_743_16 PMID: 28440253
24. Ibrahim OMA, Matsumoto Y, Dogru M, Adan ES, Wakamatsu TH, Shimazaki J, et al. In vivo confocal
microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthal-
mology. 2012 Oct; 119(10):1961–8. https://doi.org/10.1016/j.ophtha.2012.04.001 PMID: 22717457
25. Arita R, Fukuoka S, Morishige N. Meibomian Gland Dysfunction and Contact Lens Discomfort. Eye &
contact lens. 2017 Jan; 43(1):17–22
ARCH soc E sP OFTALMOL . 2 0 1 6;9 1(3):134–137
ARCHIVOS DE LA
SOCIEDAD ESPAÑOLA DE
OFTALMOLOGÍA
Short communication
A R T I C L E I N F O A B s T R A C T
Article history:
CASE report: A 75-year-old woman who had had cataract surgery in her left eye and showed a visual acuity
Received 29 November 2014
of 0.8 twenty-four hours post-surgery. Biomicroscopy revealed a foreign body attached to the iris in the nasal
Accepted 3 November 2015
sector that coincided with the main incision of the pha- coemulsification, which was then removed in a
Available online 28 February 2016
second surgical procedure. It was analyzed and described as an inert structure made of plastic.
Discussion: The possible origin of the presence of a fragment of plastic in the postoperative period
Keywords: Foreign following cataract surgery is established. In this case, its inert nature did not cause any further intraocular
body Iris inflammation. Its rigid structure also favored its attachment to the iris, thus avoiding any other complications.
Cataract surgery There must be greater preventative measures during cataract surgery, including checking the instruments and
Phacoemulsification accessories before and after the surgical procedure.
Plastic © 2015 Sociedad Espan˜ ola de Oftalmología. Published by Elsevier España, S.L.U. All rights
reserved.
R E s U M E N
PALABRas CLAve: Cuerpo
CASO clínico: Mujer de 75 an˜ os intervenida de catarata en ojo izquierdo, que presentaba a las 24 h una agudeza
extran˜ o Iris
visual de 0,8. En la biomicroscopia destacaba un cuerpo extran˜ o anclado al iris en sector nasal coincidente
Cirugía de catarata
con la incisión principal de la facoemulsificación, que fue retirado en un segundo acto quirúrgico. Fue
Facoemulsificación
analizado e informado como estructura inerte de naturaleza plástica.
Plástico
6
Please cite this article as: Santos-Bueso E, Jiménez-Santos M, Díaz-Valle D, Gegúndez-Fernández JA, Cuin˜ a-Sardin˜ a R, Benítez-del- Castillo JM, et al. Cuerpo
extran˜ o enclavado en iris después de cirugía de catarata. Arch Soc Esp Oftalmol. 2016;91:134–137.
∗
Corresponding AUTHOR.
E-mail address: esbueso@hotmail.com (E. Santos-Bueso).
2173-5794/© 2015 Sociedad Espan˜ ola de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.
ARCH soc EsP OFTALMOL . 2 0 1 6;9 1(3):134–137 135
Discusión: Planteamos el posible origen de la presencia del resto plástico en el postopera- torio de
la cirugía de la catarata. En este caso su naturaleza inerte no desencadenó mayor inflamación
intraocular. Además, la estructura rígida favoreció su anclaje al iris evitando otras complicaciones.
Deben extremarse las medidas preventivas en la cirugía de la catarata revisando incluso los
instrumentos y accesorios al terminar la cirugía.
© 2015 Sociedad Espan˜ ola de Oftalmología. Publicado por Elsevier España, S.L.U. Todos
los derechos reservados.
Introduction
Discussion
Fig. 3 – Cirrus® HD-OCT (Carl Zeiss Meditec, Dublin, California, USA) optic coherence tomography of the foreign
body fixed to the iris.
immediate postop or during a period of time that can lens haptics of 3 pieces, 16 and 20 years respec- tively after
extend several years after surgery. cataract surgery. The presence of cotton fibers in the AC
Even though the most frequent FBs are retained NFs, was observed by Shimada et al.6 in 1.7% of inter- vened
a range of FBs of different nature can be encountered. patients, a percentage which increased to 6.4% during
Varma et al.3 described a piece of metal that detached surgery. However, said cotton fibers did not produce
from the tip of the chopper and anchored in the ciliary inflam- mation within a follow-up of one year. Similarly,
angle, which later mobilized and was removed with Bakbak et al.7 considered that retained fibers did not
Micro Forceps and gonioscopy. Gokhale4 described cause additional
corneal edema secondary to a detached intraocular lens
haptic which was retained and subsequently moved
toward the corneal endothelium. Solano et al.5 described
2 cases of nontraumatic deinsertion of the intraocular
short-term inflammation and were well tolerated, in
contrast with other retained FBs.
The case presented herein is infrequent and has not
yet been described. The form and nature of the FB
indicate that it could originate from 2 possible sources.
On the one hand, it could have detached from the
plastic cover of the phacoemul- sificator handpiece.
This cover may have not been placed and adjusted
adequately and, when the phacoemulsification pro-
cess was activated, the tip of the piece could have
destroyed the plastic, observing in the elevated
structure the overlap- ping and parallel fragmentation
lines produced by ultrasound (Fig. 2). The plastic went
unnoticed during the surgery and it affixed to the iris,
which avoided its displacement toward the
iridocorneal angle of the corneal endothelium. At the
end of the surgery, said phacoemulsificator handpiece
plastic cover fragment went unnoticed.
Another hypothesis is that the plastic could have
detached from the thread used to adjust the
phacoemulsificator tip
ARCH soc EsP OFTALMOL . 2 0 1 6;9 1(3):134–137 137
Conflict of interest
Lkjopkjopkokoko[pk
Hindawi
Journal of Ophthalmology
Volume 2018, Article ID 2474173, 5 pages
https://doi.org/10.1155/2018/2474173
Research Article
Corneal Epithelial Damage and Impaired Tear Functions in
Patients with Inflamed Pinguecula
Received 30 July 2018; Revised 27 September 2018; Accepted 9 October 2018; Published 31 October 2018
(a) (b)
FIGURE 2: (a) Epithelial defect and (b) fluorescent staining in a patient with
inflamed pinguecula.